Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

v3.22.2.2
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Cash Flows from Operating Activities:        
Net income     $ 16,278,679 $ 5,409,084
Adjustments to reconcile net income to net cash used in operating activities:        
Income from investments held in Trust Account $ (1,872,086) $ (6,360) (2,493,903) (16,040)
Change in fair value of derivative warrant liabilities (4,337,200) (12,804,600) (16,419,400) (7,021,200)
Financing cost - derivative warrant liabilities       821,170
Changes in operating assets and liabilities:        
Prepaid expenses     188,607 (379,375)
Accounts payable     (40,766) 889
Accounts payable - related party     135,000 120,000
Accrued expenses     1,744,985 154,332
Net cash used in operating activities     (606,798) (911,140)
Cash Flows from Investing Activities:        
Cash deposited in Trust Account       (414,000,000)
Cash used in investing activities       (414,000,000)
Cash Flows from Financing Activities:        
Proceeds from notes payable to related parties     500,000  
Proceeds received from initial public offering, gross       414,000,000
Proceeds from private placement       10,280,000
Repayment of notes payable to related party       (185,116)
Offering costs paid       (8,715,098)
Net cash provided by financing activities     500,000 415,379,786
Net change in cash     (106,798) 468,646
Cash - beginning of the period     399,935 6,410
Cash - end of the period $ 293,137 $ 475,056 $ 293,137 475,056
Supplemental disclosure of noncash investing and financing activities:        
Offering costs included in accrued expenses       85,000
Offering costs included in notes payable       45,167
Deferred underwriting commissions in connection with the initial public offering       $ 14,490,000